Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.
Wu ZS, Wang CQ, Xiang R, Liu X, Ye S, Yang XQ, Zhang GH, Xu XC, Zhu T, Wu Q.
BMC Cancer. 2012 Feb 1;12:51.
Related citations
Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
Wu QW, She HQ, Liang J, Huang YF, Yang QM, Yang QL, Zhang ZM.
BMC Cancer. 2012 Jan 27;12:47. doi: 10.1186/1471-2407-12-47.
The cyclin-like protein Spy1/RINGO promotes mammary transformation and is elevated in human breast cancer.
Al Sorkhy M, Ferraiuolo RM, Jalili E, Malysa A, Fratiloiu AR, Sloane BF, Porter LA.
BMC Cancer. 2012 Jan 26;12:45.
Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
Mieog JS, de Kruijf EM, Bastiaannet E, Kuppen PJ, Sajet A, de Craen AJ, Smit VT, van de Velde CJ, Liefers GJ.
BMC Cancer. 2012 Jan 26;12:42. doi: 10.1186/1471-2407-12-42.
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy.
Cao MD, Giskeødegård GF, Bathen TF, Sitter B, Bofin A, Lønning PE, Lundgren S, Gribbestad IS.
BMC Cancer. 2012 Jan 25;12:39.
Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer.
Cheng TF, Wang JD, Uen WC.
BMC Cancer. 2012 Jan 21;12:33.
Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X, Zhang X, Dhakal IB, Beggs M, Kadlubar S, Luo D.
BMC Cancer. 2012 Jan 20;12:29.
TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR, Terra LF, Wailemann RA, Labriola L, Sogayar MC.
BMC Cancer. 2012 Jan 19;12:26.
NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.
de Kruijf EM, Sajet A, van Nes JG, Putter H, Smit VT, Eagle RA, Jafferji I, Trowsdale J, Liefers GJ, van de Velde CJ, Kuppen PJ.
BMC Cancer. 2012 Jan 18;12:24.
"A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".
Marsden CG, Wright MJ, Carrier L, Moroz K, Pochampally R, Rowan BG.
BMC Cancer. 2012 Jan 10;12:10.
The breast cancer genome--a key for better oncology.
Vollan HK, Caldas C.
BMC Cancer. 2011 Nov 30;11:501. Review.
Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer.
Ellberg C, Olsson H.
BMC Cancer. 2011 Nov 28;11:497.
Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study.
Su FH, Chang SN, Chen PC, Sung FC, Su CT, Yeh CC.
BMC Cancer. 2011 Nov 24;11:495.
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.
Fasching PA, Heusinger K, Haeberle L, Niklos M, Hein A, Bayer CM, Rauh C, Schulz-Wendtland R, Bani MR, Schrauder M, Kahmann L, Lux MP, Strehl JD, Hartmann A, Dimmler A, Beckmann MW, Wachter DL.
BMC Cancer. 2011 Nov 14;11:486.
The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
Hahn T, Bradley-Dunlop DJ, Hurley LH, Von-Hoff D, Gately S, Mary DL, Lu H, Penichet ML, Besselsen DG, Cole BB, Meeuwsen T, Walker E, Akporiaye ET.
BMC Cancer. 2011 Nov 2;11:471.
Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.
Keam B, Im SA, Koh Y, Han SW, Oh DY, Cho N, Kim JH, Han W, Kang KW, Moon WK, Kim TY, Park IA, Noh DY, Chung JK, Bang YJ.
BMC Cancer. 2011 Oct 20;11:452.
Clinical implication of HLA class I expression in breast cancer.
Kaneko K, Ishigami S, Kijima Y, Funasako Y, Hirata M, Okumura H, Shinchi H, Koriyama C, Ueno S, Yoshinaka H, Natsugoe S.
BMC Cancer. 2011 Oct 20;11:454. doi: 10.1186/1471-2407-11-454.
The effect of breast cancer awareness month on internet search activity--a comparison with awareness campaigns for lung and prostate cancer.
Glynn RW, Kelly JC, Coffey N, Sweeney KJ, Kerin MJ.
BMC Cancer. 2011 Oct 12;11:442.
Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR.
Strati A, Markou A, Parisi C, Politaki E, Mavroudis D, Georgoulias V, Lianidou E.
BMC Cancer. 2011 Oct 4;11:422.
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity.
Dragowska WH, Weppler SA, Qadir MA, Wong LY, Franssen Y, Baker JH, Kapanen AI, Kierkels GJ, Masin D, Minchinton AI, Gelmon KA, Bally MB.
BMC Cancer. 2011 Oct 1;11:420.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on